Example: Heart Attack

Clinical Trials on Rabies

Total 93 results

NCT03729102

Active, not recruiting

Immunological Tolerance After Frequent Rabies Booster Vaccinations

Conditions: Rabies
NCT03524417

Recruiting

Effect of ERIG Injection on Day 7 After First Dose of Rabies Vaccination to Rabies Immune Response

Conditions: Rabies
NCT03961555

Active, not recruiting

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Conditions: Rabies
NCT03228069

Active, not recruiting

Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults

Conditions: Rabies
NCT02547727

Recruiting

Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults

Conditions: Rabies
NCT03145766

Completed

Immunogenicity and Safety of a Purified Vero Rabies Vaccine

Conditions: Rabies Virus
NCT04594551

Recruiting

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland

Conditions: Rabies (Healthy Volunteers)
NCT01641315

Completed

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

Conditions: Rabies
NCT04478084

Recruiting

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

Conditions: Rabies (Healthy Volunteers)
NCT03093545

Completed

Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients

Conditions: Rabies
NCT03557008

Recruiting

Systems Biology of Inactivated Rabies Vaccine in Healthy Adults With or Without Use of Broad Spectrum Antibiotics

Conditions: Rabies Human
NCT03713086

Active, not recruiting

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Conditions: Rabies
NCT01680016

Completed

A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults

Conditions: Rabies
NCT01784874

Completed

Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use

Conditions: Rabies
NCT01388985

Completed

Simplifying the Rabies Pre-exposure Vaccination

Conditions: Rabies
NCT01610362

Completed

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

Conditions: Rabies
NCT04162600

Active, not recruiting

Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Conditions: Rabies
NCT04270838

Not yet recruiting

A Phase Ib Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Conditions: Rabies
NCT01930357

Completed

Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen

Conditions: Rabies
NCT02729168

Completed

Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly

Conditions: Rabies
NCT03774628

Completed

Immunity Duration of Rabies Vaccine and Booster Dose Effects at 10 Years Post-primary Vaccination

Conditions: Rabies
NCT01877395

Completed

Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen

Conditions: Rabies
NCT01063140

Completed

Rabies Immune Plasma Booster Study

Conditions: Rabies
NCT01173302

Unknown status

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Conditions: Rabies
NCT02241135

Completed

RNActive® Rabies Vaccine (CV7201) in Healthy Adults

Conditions: Rabies